Hybio Pharmaceutical's major shareholders unpledge significant shareholdings

Hybio Pharmaceutical announced that its controlling shareholders and actual controllers, Zeng Shaogui and Zeng Qiang, have completed the partial release of pledged shares. Zeng Shaogui unpledged a total of 23,295,875 shares across three transactions, representing 23.64% of his total holdings and 2.64% of the company's total share capital. Zeng Qiang unpledged 11,156,006 shares, equating to 17.67% of his holdings and 1.26% of the company's total share capital. All these shares were pledged to Shenzhen Guarantee Group Co., Ltd., with a release date set for September 30, 2025.

Following these releases, the total number of unpledged shares by these key individuals amounts to 34,451,881, representing 3.90% of the company's total share capital. As of the announcement date, Zeng Shaogui's pledged shares now total 41,190,000, or 41.80% of his holdings. Zeng Qiang's pledged shares stand at 26,500,000, representing 41.97% of his holdings.

Cumulatively, the controlling shareholders and actual controllers have 76,190,000 shares still pledged, accounting for 41.55% of their total holdings and 8.63% of the company's total share capital. This partial release signifies a notable change in their financial arrangements concerning company shares.